PAR 3.45% 28.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm to present at NWR Virtual Conference, page-37

  1. 572 Posts.
    lightbulb Created with Sketch. 141
    Excellent presentation.

    In the Executive Summary slide at 3.42 they state "Seeking Provisional Approval in Australia with TGA prior to completing the Phase 3 trial" but this is not actually discussed in the presentation.

    On what basis can provisional approval in Australia be sought (given that it is prior to the trial results) and what are expectations are around the timing of this?

    "Completing the Phase 3 trial" is not until 2022 so I am just trying to get a handle on the possible kick off time in Australia.

    I am thinking that around the time PAR really begins rolling out PPS in Australia there will be a lot of new interest from investors and institutions.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
28.0¢
Change
-0.010(3.45%)
Mkt cap ! $97.94M
Open High Low Value Volume
29.0¢ 29.5¢ 28.0¢ $40.10K 140.9K

Buyers (Bids)

No. Vol. Price($)
5 135929 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
28.5¢ 20969 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.